Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas, MIMETAS Enter Strategic Immuno-Oncology Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Astellas, MIMETAS Enter Strategic Immuno-Oncology Alliance

Astellas will receive access to MIMETAS immune oncological disease assays.

By: Anthony Vecchione

Mimetas, a company involved in human disease modeling, has entered into a strategic partnership with Astellas Pharma Inc., a global pharmaceutical company. The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies.

Under the partnership, Astellas will receive access to MIMETAS immune oncological disease assays. MIMETAS will be eligible for upfront and milestone payments.

“We are excited to make this next step in our longstanding collaboration with Astellas,” Paul Vulto, CEO of MIMETAS, said. “Astellas is among Japan’s most innovative pharmaceutical companies with ambitious programs on cancer cell therapies and bispecific immune cell engagers. MIMETAS has the expertise and technology to capture the complexity of tumors and their microenvironments.”

Vulto added: “This crucial piece of a puzzle allows us to understand tumor biology more deeply and supports Astellas’ ambition to substantially increase response rate to immuno-oncological treatments.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics